MAIA Biotechnology, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

COMMITMENTS AND CONTINGENCIES (Details Narrative)

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended				12 Months Ended
	Dec. 31, 2024	Feb. 28, 2021	Dec. 31, 2020	Nov. 30, 2018	Dec. 31, 2025
Regeneron Pharmaceuticals Inc [Member]
Loss Contingencies [Line Items]
Term of agreement		5 years
BeiGene Swizerland Gmb H [Member]
Loss Contingencies [Line Items]
Term of agreement	7 years
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member]
Loss Contingencies [Line Items]
Term of agreement				20 years
Combined milestone payment maximum				$ 112,000,000
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Milestone payment				$ 1,000,000
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member] \| Minimum [Member] \| Net Sales Up to $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales				2.00%
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member] \| Minimum [Member] \| Net Sales Above $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales				2.50%
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Milestone payment				$ 50,000,000
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member] \| Maximum [Member] \| Net Sales Up to $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales				4.00%
Ateganosine THIO Therapeutics Inc [Member] \| Amended Patent And Technology License Agreement [Member] \| Maximum [Member] \| Net Sales Above $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales				5.00%
University Of Texas Southwestern [Member] \| Amended Patent And Technology License Agreement [Member]
Loss Contingencies [Line Items]
Payments due related to milestones					$ 0
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member]
Loss Contingencies [Line Items]
Term of agreement			20 years
Combined milestone payment maximum			$ 112,000,000
Percentage of royalty description					There are single digit royalty rates for licensed products and licensed services covered by a Valid Claim (as defined in the agreement) and dependent on whether Net Sales are greater than or less than/equal to $1,000,000,000, with Net Sales above that amount commanding a slightly higher percentage. In each case, the royalty percentage is lower before patent issuance in each jurisdiction. In the event that the licensed product or licensed service is not covered by a Valid Claim, the running royalty rates are reduced by fifty percent (50%).
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Milestone payment			$ 1,000,000
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member] \| Minimum [Member] \| Net Sales Up to $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales			2.00%
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member] \| Minimum [Member] \| Net Sales Above $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales			2.50%
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Milestone payment			$ 50,000,000
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member] \| Maximum [Member] \| Net Sales Up to $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales			4.00%
University Of Texas Southwestern [Member] \| Patent And Technology License Agreement [Member] \| Maximum [Member] \| Net Sales Above $1,000,000,000 [Member]
Loss Contingencies [Line Items]
Rate of royalties on net sales			5.00%